Health and Wellness
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.
Users will have the option to participate in groups and schedule a coaching session.
AmerisourceBergen will support the distribution of h2o's Apple Watch-enabled prescription digital therapeutic for Parkinson's disease monitoring.
The group who received an interactive DVD and patient navigation services delivered by phone was nearly six times more likely to be up-to-date on breast, cervical and colorectal cancer screenings compared with a cohort who received usual care.
The company said it plans to use the Series A to expand in the U.K. and Europe, as well as to enter the U.S. market.
The Translational Research Institute for Space Health is seeking proposals for a health and data platform for space travel.